Publication | Closed Access

The Anti-fibrotic and Anti-inflammatory Potential of Bone Marrow–Derived Mesenchymal Stem Cells and Nintedanib in Bleomycin-Induced Lung Fibrosis in Rats

Regenerative MedicineInflammationFibrosisAntifibrotic TherapyInflammatory Lung DiseaseBleomycin-induced Lung FibrosisLung InflammationAnti-inflammatory PotentialMedicineImmunologyPharmacologyPulmonary PharmacologyStem Cell ResearchPulmonary FibrosisStem-cell TherapyMesenchymal Stem CellStem CellsCell Biology